Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HT<sub>1e</sub>R and 5-HT<sub>1F</sub>R.
Ontology highlight
ABSTRACT: Serotonin [5-hydroxytryptamine (5-HT)] acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HT1eR have confirmed roles in native tissue and are validated drug targets. Despite 5-HT1eR's therapeutic potential and plausible druggability, the mechanisms of its activation remain elusive. To illuminate 5-HT1eR's pharmacology in relation to the highly homologous 5-HT1FR, we screened a library of aminergic receptor ligands at both receptors and observe 5-HT1eR/5-HT1FR agonism by multicyclic drugs described as pan-antagonists at 5-HT receptors. Potent agonism by tetracyclic antidepressants mianserin, setiptiline, and mirtazapine suggests a mechanism for their clinically observed antimigraine properties. U
SUBMITTER: Zilberg G
PROVIDER: S-EPMC11023502 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA